Classical QSAR modeling of anti-HIV 2,3-diaryl-1,3-thiazolidin-4-ones

QSAR and Combinatorial Science

Volumn 24, Issue 5, 2005, Pages 579-592

  Roy, Kunal ^a   Leonard, J Thomas ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

2,3 Diaryl 1,3 thiazolidin 4 ones; AM1 calculations; Anti HIV activity; Fujita Ban model; Hansch analysis; QSAR; Topological parameters

Indexed keywords

COMPUTATIONAL CHEMISTRY; CYTOTOXICITY; MOLECULAR GRAPHICS; PRINCIPAL COMPONENT ANALYSIS; REGRESSION ANALYSIS;

2,3-DIARYL-1,3-THIAZOLIDIN-4-ONE; AM1 CALCULATIONS; ANTI-HIV ACTIVITY; CYTOPROTECTION; FUJITA-BAN MODEL; HANSCH ANALYSE; LEAVE ONE OUT; QSAR; THIAZOLIDIN-4-ONES; TOPOLOGICAL PARAMETERS;

TOPOLOGY;

1,3 THIAZOLIDIN 4 ONE DERIVATIVE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; THIAZOLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTIVIRAL ACTIVITY; ARTICLE; CALCULATION; CELL PROTECTION; CYTOTOXICITY; ELECTRICITY; FUJITA BAN ANALYSIS; HANSCH ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROPHOBICITY; MATHEMATICAL ANALYSIS; MULTIPLE REGRESSION; PHYSICAL CHEMISTRY; PREDICTION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL ANALYSIS; STEREOCHEMISTRY; STRUCTURE ANALYSIS; VALIDATION PROCESS;

HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 23044466157     PISSN: 1611020X     EISSN: None     Source Type: Journal    
DOI: 10.1002/qsar.200430901     Document Type: Article

References (47)

1. G. Campiani, A. Ramunno, G. Maga, V. Nacci, C. Fattorusso, B. Catalanotti, E. Morelli, E. Novellino, Cur. Pharm. Des. 2002, 8, 615-657.
2. http://www.unaids.org/Unaids/EN/Resources/Publications
3. M. Schweizer, E. Flory, C. J. Buchholz, K. Cichutek, Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz. 2001, 44, 1038-1046.
4. F. Chang, F. Re, S. Sebastian, S. Sazer, J. Luban, Mol. Bio. Cel. 2004, 15, 1793-1801.
5. S. Jiang, Q. Zhao, A. K. Debanth, Cur. Pharm. Des. 2002, 8, 563-580.
6. R. W. Sanders, M. M. Dankers, E. Busser, M. Caffrey, J. P. Moore, B. Berkhout, Retrovirology. 2004, 1, 3-13.
7. P. P. Mager, Med. Res. Rev. 2001, 21, 348-351.
8. J. M. Farber, E. A. Berger, Proc. Natl. Acad. Sci. USA. 2002, 99, 1749-1751.
9. D. D. Richman, Nature. 2001, 410, 995-1001.
10. W. Kazmierski, N. Bifulco, H. Yang, L. Boone, F. DeAnda, C. Watson, T. Kenakin, Bioorg. Med. Chem. 2003, 11, 2663-2676.
11. F. Tsamis, S. Gavrilov, F. Kajumo, C. Seibert, S. Kuhmann, T. Ketas, A. Trkola, A. Palani, J. W. Clader, J. R. Tagat, S. McCombie, B. Baroudy, J. P. Moore, T. P. Sakmar, T. Dragic, J. Virol. 2003, 77, 5201-5208.
12. G. Xu, A. Kannan, T. L. Hartman, H. Wargo, K. Watson, J. A. Turpin, R. W. Jr. Buckheit, A. A. Johnson, Y. Pommier, M. Cushman, Bioorg. Med. Chem. 2002, 10, 2807-2816.
13. M. Stevens, C. Pannecouque, E. DeClercq, J. Balzarini, Antimicrob. Agents Chemother. 2003, 47, 3109-3116.
14. J. T. Leonard, K. Roy, QSAR Comb. Sci. 2004, 23, 23-35.
15. K. Roy, J. T. Leonard, Bioorg. Med. Chem. 2004, 12, 745-754.
16. J. T. Leonard, K. Roy, Drug Des. Discov. 2003, 18, 165-180.
17. J. T. Leonard, K. Roy, QSAR Comb. Sci. 2004, 23, 387-398.
18. A. Rao, J. Balzarini, A. Carbone, A. Chimirri, E. De Clercq, A. M. Monforte, P. Monforte, C. Pannecouque, M. Zappala, Farmaco. 2004, 59, 33-39.
19. M. L. Barreca, A. Chimirri, E. De Clercq, L. De Luca, A. M. Monforte, P. Monforte, A. Rao, M. Zappala, Farmaco. 2003, 58, 259-263.
20. A. Rao, A. Carbone, A. Chimirri, E. De Clercq, A. M. Monforte, P. Monforte, C. Pannecouque, M. Zappala, Farmaco. 2003, 58, 115-120.
21. A. Rao, A. Carbone, A. Chimirri, E. De Clercq, A.M. Monforte, P. Monforte, C. Pannecouque, M. Zappala, Farmaco. 2002, 57, 747-751.
22. M. L. Barreca, J. Baizarini, A. Chimirri, E. De Clercq, L. De Luca, H. D. Holtje, M. Holtje, A. M. Monforte, P. Monforte, C. Pannecouque, A. Rao, M. Zappala, J. Med. Chem. 2002, 45, 5410-5413.
23. M. L. Barreca, A. Chimirri, L. De Luca, A. M. Monforte, P. Monforte, A. Rao, M. Zappala, J. Baizarini, E. De Clercq, C. Pannecouque, M. Witvrouw, Bioorg. Med. Chem. Lett. 2001, 11, 1793-1796.
24. T. Fujita, T. Ban, J. Med. Chem. 1971, 14, 148-152.
25. H. Kubinyi, O. H. Kehrhahn, J. Med. Chem. 1976, 19, 1040-1049.
26. H. Kubinyi, O. H. Kehrhahn, J. Med. Chem. 1976, 19, 578-586.
27. H. Kubinyi, J. Med. Chem. 1976, 19, 587-600.
28. C. Mansch, T. Fujita, J. Am. Chem. Soc. 1964, 86, 1616-1626.
29. C. Hansch, A. Leo, D. Hoekman, in: Exploring QSAR. Hydrophobic, Electronic and Steric Constants, American Chemical Society, Washington, DC, 1995.
30. 2 version 4.8 is a product of Accelrys, Inc., San Diego, USA.
31. M. J. S. Dewar, E. G. Zoebisch, E. F. Healey, J. J. P. Stewart, J. Am. Chem. Soc. 1985, 107, 3902-3909.
32. M. J. S. Dewar, C. H. Hwang, D. R. Kuhn, J. Am. Chem. Soc. 1991, 113, 735-741.
33. P. U. Civcir, J. Mol. Struct.: THEOCHEM. 2001, 555, 121-129.
34. Chem 3D Pro version 5.0 is a program of CambridgeSoft Corporation, MA, U.S.A.
35. K. Roy, A. U. De, C. Sengupta, Quant. Struct.-Act. Relat. 2001, 20, 319-326.
36. K. Roy, QSAR Comb. Sci. 2003, 22, 614-621.
37. K. Roy, J. T. Leonard, C. Sengupta, Bioorg. Med. Chem Lett. 2004, 14, 3705-3709.
38. R. Franke, Theoretical Drug Design Methods, Elsevier, Amsterdam 1984, pp. 184-195.
39. R. Franke, A. Gruska, Principal component and factor analysis, in: H. van de Waterbeemd, (Ed.), Chemometric Methods in Molecular Design, VCH, Weinheim, 1995, pp. 113-163.
40. SPSS is a statistical software of SPSS Inc., IL, USA.
41. G. W. Snedecor, W. G. Cochran, Statistical Methods, Oxford & IBH Publishing Co. Pvt. Ltd., New Delhi 1967, pp. 381-418.
42. S. Wold, L. Eriksson, Statistical Validation of QSAR Results, in: H. van de Waterbeemd, (Ed), Chemometric Methods in Molecular Design, VCH, Weinheim, 1995, pp. 312-317.
43. A. K. Debnath, Quantitative Structure-Activity Relationship (QSAR): A Versatile Tool in Drug Design, in: A. K. Ghose, V. N. Viswanadhan, (Eds.), Combinatorial Library design and Evaluation, Marcel Dekker, Inc. New York 2001, pp. 73-129.
44. J. D. Walker, J. Jaworska, M. H. Comber, T. W. Schultz, J. C. Dearden, Environ. Toxicol. Chem. 2003, 22, 1653-1665.
45. L. Eriksson, J. Jaworska, A. P. Worth, M. T. D. Cronin, R. M. McDowell, P. Gramatica, Environ. Health Perspect. 2003, 111, 1361-1375.
46. Y. S. Prabhakar, V. R. Solomon, R. K. Rawal, M. K. Gupta, S. B. Katti, QSAR Comb. Sci. 2004, 23, 234-244.
47. M. L. Barreca, A. Carotti, A. Carrieri, A. Chimirri, A. M. Monforte, M. P. Calace, A. Rao, Bioorg. Med. Chem. 1999, 7, 2283-2292.